| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |